NM_006312.6:c.1813+623G>C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_006312.6(NCOR2):c.1813+623G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 31)
Failed GnomAD Quality Control
Consequence
NCOR2
NM_006312.6 intron
NM_006312.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.83
Publications
6 publications found
Genes affected
NCOR2 (HGNC:7673): (nuclear receptor corepressor 2) This gene encodes a nuclear receptor co-repressor that mediates transcriptional silencing of certain target genes. The encoded protein is a member of a family of thyroid hormone- and retinoic acid receptor-associated co-repressors. This protein acts as part of a multisubunit complex which includes histone deacetylases to modify chromatin structure that prevents basal transcriptional activity of target genes. Aberrant expression of this gene is associated with certain cancers. Alternate splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NCOR2 | NM_006312.6 | c.1813+623G>C | intron_variant | Intron 17 of 48 | ENST00000405201.6 | NP_006303.4 | ||
| NCOR2 | NM_001206654.2 | c.1810+623G>C | intron_variant | Intron 17 of 47 | NP_001193583.1 | |||
| NCOR2 | NM_001077261.4 | c.1810+623G>C | intron_variant | Intron 17 of 47 | NP_001070729.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NCOR2 | ENST00000405201.6 | c.1813+623G>C | intron_variant | Intron 17 of 48 | 1 | NM_006312.6 | ENSP00000384018.1 | |||
| NCOR2 | ENST00000429285.6 | c.1810+623G>C | intron_variant | Intron 16 of 46 | 1 | ENSP00000400281.2 | ||||
| NCOR2 | ENST00000404621.5 | c.1810+623G>C | intron_variant | Intron 16 of 46 | 1 | ENSP00000384202.1 | ||||
| NCOR2 | ENST00000458234.5 | c.1813+623G>C | intron_variant | Intron 17 of 32 | 1 | ENSP00000402808.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 151914Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
0
AN:
151914
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 151914Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74190
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74190
African (AFR)
AF:
AC:
0
AN:
41348
American (AMR)
AF:
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10544
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67970
Other (OTH)
AF:
AC:
0
AN:
2088
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.